𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Functional impairment of p16INK4A due to CDKN2A p.Gly23Asp missense mutation

✍ Scribed by Maria Chiara Scaini; Elisabetta Rossi; Paula Lobao Antunes de Siqueira Torres; Daniela Zullato; Monia Callegaro; Cinzia Casella; Monica Quaggio; Simona Agata; Sandro Malacrida; Vanna Chiarion-Sileni; Antonella Vecchiato; Mauro Alaibac; Marco Montagna; Graham J. Mann; Chiara Menin; Emma D’Andrea


Book ID
113809360
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
672 KB
Volume
671
Category
Article
ISSN
0027-5107

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Predicting functional significance of ca
✍ Heather A. McKenzie; Carina Fung; Therese M. Becker; Mal Irvine; Graham J. Mann; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB 👁 1 views

Inherited mutations affecting the INK4a/ARF locus (CDKN2A) are associated with melanoma susceptibility in 40% of multiple case melanoma families. Over 60 different germline INK4a/ARF mutations have been detected in more than 190 families worldwide. The majority of these alterations are missense muta

No p16INK4A/CDKN2/MTS1 mutations indepen
✍ Meye, Axel; Würl, Peter; Hinze, Raoul; Berger, Dieter; Bache, Matthias; Schmidt, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

The p16 INK4A /CDKN2/MTS1 gene encodes a specific inhibitor of cyclin-dependent kinases (CDKs) 4 and 6. This study investigates p16 INK4A gene status and expression in mesenchymal tumours, in particular soft tissue sarcomas (STSs). Employing non-radioactive polymerase chain reaction-single strand co

Cdkn2a encodes functional variation of p
✍ Christopher R. Herzog; Seong Noh; Laura E. Lantry; Kuan-Liang Guan; Ming You 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

The cyclin-dependent kinase inhibitor 2a (Cdkn2a) locus encodes two distinct tumor suppressors, p16INK4a and p19ARF, whose functions interrelate in the regulation of cell proliferation as key components of the retinoblastoma and p53 pathways, respectively. In many types of cancer, alterations of Cdk